• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新思考对所有乳腺硬化性病变行常规外科切除术。

Rethinking Routine Surgical Excision for all Radial Sclerosing Lesions of the Breast.

机构信息

University of Kansas Medical Center, Kansas City, Kansas.

Division of Breast Imaging, Department of Radiology, The University of Kansas Health System, Kansas City, Kansas.

出版信息

J Surg Res. 2022 Nov;279:611-618. doi: 10.1016/j.jss.2022.06.048. Epub 2022 Aug 1.

DOI:10.1016/j.jss.2022.06.048
PMID:35926311
Abstract

INTRODUCTION

The need for routine surgical excision of a radial sclerosing lesions (RSL) of the breast identified on percutaneous biopsy remains controversial, as contemporary upgrade rates are lower than historically cited.

MATERIALS AND METHODS

A prospectively-maintained database of high-risk breast biopsies undergoing multidisciplinary review at a single institution was queried to identify cases of RSL from 2/2015 to 11/2020. Demographic, radiologic, and pathologic variables were summarized using frequencies and analyzed in association with RSL excision status using mixed-effects logistic regression or Fisher's exact tests.

RESULTS

217 RSL were identified, diagnosed at a mean age of 57 y. The median imaging size was 1.3 cm and the majority had estimated >50% of the target removed by core needle biopsy. 32.3% underwent surgical excision of the RSL biopsy site and 2/70 (2.9%) upgraded to ductal carcinoma in situ (DCIS) on final surgical pathology. Upgrade was significantly higher for atypical RSL (P = 0.02). None of the RSL (n = 60) without atypia who had undergone excision were upgraded. For those omitting surgical excision, there was no subsequent breast cancer diagnosis at the RSL site over a mean follow-up of 23 mo.

CONCLUSIONS

Surgical excision may be omitted for RSL without atypia as this group has 0% risk of upgrade after multidisciplinary review.

摘要

简介

在经皮活检中发现的乳腺放射性硬化性病变(RSL)需要常规手术切除,但这仍然存在争议,因为目前的升级率低于历史报道。

材料与方法

对一家机构进行的多学科审查的高风险乳腺活检的前瞻性维护数据库进行了查询,以确定 2015 年 2 月至 2020 年 11 月期间的 RSL 病例。使用频率总结了人口统计学、影像学和病理学变量,并使用混合效应逻辑回归或 Fisher 精确检验分析了与 RSL 切除状态的关联。

结果

共发现 217 例 RSL,平均年龄为 57 岁。影像学大小中位数为 1.3cm,大多数患者通过核心针活检切除了>50%的目标组织。32.3%的患者进行了 RSL 活检部位的手术切除,70 例中有 2 例(2.9%)在最终外科病理中升级为导管原位癌(DCIS)。非典型 RSL 的升级率显著更高(P=0.02)。无典型增生的 60 例 RSL(n=60)中,无 1 例在切除后升级。对于那些不进行手术切除的患者,在平均 23 个月的随访中,RSL 部位没有后续的乳腺癌诊断。

结论

对于无非典型增生的 RSL,可以省略手术切除,因为多学科审查后这组患者升级的风险为 0%。

相似文献

1
Rethinking Routine Surgical Excision for all Radial Sclerosing Lesions of the Breast.重新思考对所有乳腺硬化性病变行常规外科切除术。
J Surg Res. 2022 Nov;279:611-618. doi: 10.1016/j.jss.2022.06.048. Epub 2022 Aug 1.
2
Complex sclerosing lesions and radial sclerosing lesions on core needle biopsy: Low risk of carcinoma on excision in cases with clinical and imaging concordance.粗针活检时的复杂性硬化性病变和放射状硬化性病变:临床与影像学表现一致的病例切除术后发生癌变的风险较低。
Breast J. 2018 Mar;24(2):133-138. doi: 10.1111/tbj.12859. Epub 2017 Jul 7.
3
Radial sclerosing lesions found on core needle biopsy: excision can be safely avoided.在粗针活检中发现的放射性硬化性病变:可安全避免切除。
Histopathology. 2024 Sep;85(3):397-404. doi: 10.1111/his.15233. Epub 2024 Jun 6.
4
Radial scars diagnosed on breast core biopsy: Frequency of atypia and carcinoma on excision and implications for management.乳腺粗针活检诊断为放射状瘢痕:切除时非典型增生和癌的发生率及其对治疗的意义。
Breast. 2016 Dec;30:201-207. doi: 10.1016/j.breast.2016.06.007. Epub 2016 Jun 29.
5
Clinical and Radiologic Follow-up Study for Biopsy Diagnosis of Radial Scar/Radial Sclerosing Lesion without Other Atypia.无其他异型性的放射状瘢痕/放射状硬化性病变活检诊断的临床及影像学随访研究
Breast J. 2016 Nov;22(6):637-644. doi: 10.1111/tbj.12645. Epub 2016 Aug 19.
6
Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study.乳腺核心活检中诊断的伴有非典型上皮增生的放射状瘢痕/复杂硬化性病变的转归:一项基于英国的多中心研究结果。
J Clin Pathol. 2019 Dec;72(12):800-804. doi: 10.1136/jclinpath-2019-205764. Epub 2019 Jul 26.
7
High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.MRI 引导核心活检检测到的高危病变:手术切除时的升级率及对管理的影响。
AJR Am J Roentgenol. 2021 Mar;216(3):622-632. doi: 10.2214/AJR.20.23040. Epub 2021 Jan 13.
8
Radial Scar at Percutaneous Breast Biopsy That Does Not Require Surgery.经皮乳腺活检时出现的无需手术的放射状瘢痕。
J Am Coll Surg. 2016 Nov;223(5):712-716. doi: 10.1016/j.jamcollsurg.2016.08.003. Epub 2016 Aug 16.
9
Ipsilateral and Concurrent Breast Cancer and Atypical Ductal Hyperplasia: Does Atypia Also Need Surgical Excision?同侧及同时性乳腺癌与非典型导管增生:非典型增生是否也需要手术切除?
Ann Surg Oncol. 2020 Nov;27(12):4786-4794. doi: 10.1245/s10434-020-08896-7. Epub 2020 Jul 23.
10
Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary?乳腺不确定恶性潜能手术切除病变的长期随访价值——5 年是否必要?
Clin Breast Cancer. 2022 Oct;22(7):699-704. doi: 10.1016/j.clbc.2022.05.009. Epub 2022 Jun 2.

引用本文的文献

1
[Interpretation of Image-Guided Biopsy Results and Assessment].[影像引导下活检结果的解读与评估]
J Korean Soc Radiol. 2023 Mar;84(2):361-371. doi: 10.3348/jksr.2022.0164. Epub 2023 Mar 28.
2
[B3 lesions of the breast: histological, clinical, and epidemiological aspects : Update].[乳腺B3病变:组织学、临床及流行病学方面:最新进展]
Pathologie (Heidelb). 2023 Feb;44(1):5-16. doi: 10.1007/s00292-022-01180-3. Epub 2023 Jan 12.